GlassScriptPhysician profile
Julio Davalos
NPI 1548343064
$490,008.53
in general payments reported to CMS, 2019-2025
58 companies · $3,146 in 2025
The $3,146 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199K · 2020: $33K · 2021: $106K · 2022: $81K · 2023: $48K · 2024: $20K · 2025: $3,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Food and Beverage: $7,256 · Consulting Fee: $3,413 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,696.79 |
| Food and Beverage | $7,256.06 |
| Consulting Fee | $3,412.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $400,178.40 | 2019-2025 | Lithoclast, General - Kidney Stone Disease, 8/10 Dilator/Sheath Set |
| Karl Storz Endoscopy-America | $53,128.78 | 2019-2021 | |
| Lumenis LTD. | $15,000.00 | 2021 | |
| Ethicon INC. | $14,127.08 | 2021 | |
| Janssen Biotech, INC. | $723.78 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $612.01 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $544.84 | 2019-2025 | Speedicath, Porges Coloplast |
| Astellas Pharma US INC | $528.89 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $355.75 | 2020-2025 | Botox |
| Teleflex LLC | $342.20 | 2022-2024 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $323.16 | 2021-2025 | |
| Urogen Pharma, INC. | $299.32 | 2022-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $288.58 | 2022-2024 | Pylarify |
| Merck Sharp & Dohme LLC | $272.44 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Ferring Pharmaceuticals INC. | $260.84 | 2019-2025 | Adstiladrin |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $247.79 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $230.74 | 2019-2022 | |
| Antares Pharma, INC. | $211.08 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $197.86 | 2022-2024 | Interstim |
| Olympus America INC. | $177.19 | 2019-2023 | Itind System |
| Urovant Sciences INC | $173.40 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $151.75 | 2019-2022 | |
| Calyxo, INC. | $137.03 | 2025 | Cvac Aspiration System |
| Immunitybio, INC. | $135.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $129.01 | 2022-2025 | |
| Amgen INC. | $126.46 | 2019-2023 | Prolia |
| Myovant Sciences INC. | $123.98 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $88.20 | 2021-2023 | Givlaari |
| Allergan, INC. | $76.45 | 2019-2020 | |
| Renovia INC | $67.64 | 2019 | |
| Novo Nordisk INC | $62.28 | 2024-2025 | Rivfloza |
| Clarus Therapeutics INC. | $61.25 | 2021 | |
| Myriad Genetic Laboratories, INC. | $57.55 | 2021-2022 | |
| Dentsply Ih Ab | $46.35 | 2023-2025 | Lofric, Lofric |
| Travere Therapeutics, INC. | $39.55 | 2019 | |
| Tolmar, INC. | $39.24 | 2023-2025 | Jatenzo, Eligard |
| Pfizer INC. | $37.43 | 2019-2025 | |
| Accord Healthcare, INC. | $36.79 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Sun Pharmaceutical Industries INC. | $28.10 | 2025 | |
| Tempus Ai, INC | $27.14 | 2024 | Xt Cdx |
| Zyla Life Sciences, INC. | $26.83 | 2019 | |
| Baxter Healthcare | $26.29 | 2019 | |
| Endo USA, INC. | $20.49 | 2024 | Aveed, Xiaflex |
| Janssen Scientific Affairs, LLC | $20.12 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.99 | 2025 | |
| Bioprotect Medical, INC. | $19.37 | 2025 | Bioprotect Balloon Implant System |
| Intuitive Surgical, INC. | $18.47 | 2019 | |
| 180 Medical, INC. | $18.46 | 2023 | Cure Catheter |
| Palette Life Sciences, INC. | $17.71 | 2022 | |
| Mission Pharmacal Company | $16.54 | 2022 | |
| Abc Home Medical Supply, INC. | $16.09 | 2024 | |
| Acerus Pharmaceuticals Corporation | $15.06 | 2022 | |
| Caris Mpi, INC. | $14.25 | 2025 | Mi Cancer Seek |
| Metuchen Pharmaceuticals | $14.22 | 2019 | |
| Angiodynamics, INC. | $14.08 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Davalos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.